Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study

Neuropsychiatric Disease and Treatment ◽

10.2147/ndt.s10184 ◽

2010 ◽

pp. 71 ◽

Author(s):

Mike Briley

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Outpatient Treatment ◽

Exploratory Study ◽

Major Depressive ◽

Download Full-text

Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/00004850-200505000-00002 ◽

2005 ◽

Vol 20 (3) ◽

pp. 131-137 ◽

Author(s):

Nicholas Moore ◽

H??l??ne Verdoux ◽

Bruno Fantino

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Outpatient Treatment ◽

Blind Study ◽

Double Blind Study ◽

Major Depressive ◽

Download Full-text

Corrigendum to ``The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram'' [Journal of Affective Disorders, 227 (2018) 803–809]

Journal of Affective Disorders ◽

10.1016/j.jad.2018.03.011 ◽

2018 ◽

Vol 236 ◽

pp. 319 ◽

Author(s):

Eduard Vieta ◽

Lasse B. Sluth ◽

Christina K. Olsen

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Cognitive Dysfunction ◽

Affective Disorders ◽

Exploratory Study ◽

Inadequate Response ◽

Major Depressive ◽

Download Full-text

The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: A short-term, randomized, double-blind, exploratory study

Journal of Affective Disorders ◽

10.1016/j.jad.2017.12.056 ◽

2018 ◽

Vol 229 ◽

pp. 421-428 ◽

Author(s):

Bernhard T. Baune ◽

Lasse B. Sluth ◽

Christina K. Olsen

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Cognitive Performance ◽

Exploratory Study ◽

Major Depressive ◽

Download Full-text

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study

International Clinical Psychopharmacology ◽

10.1097/yic.0000000000000326 ◽

2020 ◽

Vol 35 (6) ◽

pp. 305-312

Author(s):

Elmars Rancans ◽

Janos Zambori ◽

Mads Dalsgaard ◽

Corine Baayen ◽

Johan Areberg ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Exploratory Study ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram

Journal of Affective Disorders ◽

10.1016/j.jad.2017.11.053 ◽

2018 ◽

Vol 227 ◽

pp. 803-809 ◽

Author(s):

Eduard Vieta ◽

Lasse B. Sluth ◽

Christina K. Olsen

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Cognitive Dysfunction ◽

Exploratory Study ◽

Inadequate Response ◽

Major Depressive ◽

Download Full-text

SAGE-217 in major depressive disorder: a multicenter, randomized, double-blind, Phase 2 placebo-controlled trial

10.26226/morressier.5b68175eb56e9b005965c44b ◽

2018 ◽

Author(s):

Handan Gunduz-Bruce

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Controlled Trial ◽

Phase 2 ◽

Major Depressive ◽

Download Full-text

Faculty Opinions recommendation of Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1103835.559964 ◽

2008 ◽

Author(s):

Deborah Kim

Keyword(s):

Fatty Acids ◽

Major Depressive Disorder ◽

Depressive Disorder ◽

Controlled Trial ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2356957.1984055 ◽

2010 ◽

Author(s):

Shailesh Jain

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Treatment Initiation ◽

Randomized Study ◽

Major Depressive ◽

Double Blind ◽

Antidepressant Medications

Download Full-text

Statement of Retraction: Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study

International Journal of Psychiatry in Clinical Practice ◽

10.1080/13651501.2021.1950437 ◽

2021 ◽

pp. 1-1

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Controlled Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: A randomized, double-blinded, exploratory study with vortioxetine

Journal of Affective Disorders ◽

10.1016/j.jad.2019.02.006 ◽

2019 ◽

Vol 250 ◽

pp. 35-42 ◽

Author(s):

A.A. Nierenberg ◽

H. Loft ◽

C.K. Olsen

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Exploratory Study ◽

Treatment Effects ◽

Cognitive Symptoms ◽

Major Depressive ◽

Download Full-text